InvestorsHub Logo
icon url

centsability4me

06/09/21 12:17 PM

#35498 RE: BEIJING BILL #35497

Bill,

Ichim R & D is spread among several companies, and w/ other inventors

Marincola, Ichim and Kesari on pubmed :

Unleashing endogenous TNF-alpha as a cancer immunotherapeutic

https://pubmed.ncbi.nlm.nih.gov/30170620/


Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique? ( Add Amit Patel- (JadiCell) , and Hong Ma-TSOI , and Sam Wagner of Batu Biologics to the list of inventors including Marincola, Ichim, and Kesari)

https://pubmed.ncbi.nlm.nih.gov/26510973/
icon url

doogdilinger

06/09/21 12:40 PM

#35501 RE: BEIJING BILL #35497

Agreed BILL buddy! Any penny player remotely serious about the opportunity here needs to read every single PR and filing ever unveiled/released to date. Then they need to further do the available due diligence by reading every single CEO Tim Dixon TSOI shareholder forum update provided.

CEO Dixon has done an absolute killer job at keeping the TSOI core shareholder base informed on the real world opportunity that exists here. And I applaud him for never crossing any lines in that delicate process. Because he's been extremely careful in all his wording, while making sure to actually educate the investors amongst us who want to fully understand the potential inherent value that truly exists within TSOI's 47 filed IP's right cheers!